Back to search

Article

A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria

2021-11-03

Abstract excerpt

<h4>Introductory paragraph</h4> The apicomplexa comprise a large phylum of single-celled, obligate intracellular protozoa that infect humans and animals and cause severe parasitic diseases. Available therapeutics against these devastating diseases are limited by suboptimal efficacy and frequent side effects, as well as the emergence and spread of resistance. Here, we use a drug repurposing strategy and identify a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf89fb9e-9cd5-5826-918e-12e01e319915
DOI
10.1101/2021.11.03.467097
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malariaDOI 10.1101/2021.11.03.467097
Select a neighboring publication to make it the new centre.